The use of antifungal therapy in neonatal intensive care.

Clinics in Perinatology
Daniela TestoniDaniel K Benjamin

Abstract

Invasive fungal infections remain a significant cause of infection-related mortality and morbidity in preterm infants. Central nervous system involvement is the hallmark of neonatal candidiasis, differentiating the disease's impact on young infants from that among all other patient populations. Over the past decade, the number of antifungal agents in development has grown, but most are not labeled for use in newborns. We summarize the findings of several antifungal studies that have been completed to date, emphasizing those including infant populations. We conclude that more studies are required for antifungals to be used safely and effectively in infants.

References

Mar 1, 1977·Annals of Internal Medicine·J E Bennet
Jan 1, 1975·Chemotherapy·A Polak, H J Scholer
Oct 1, 1992·Clinical Pharmacokinetics·R JanknegtD J Crommelin
Mar 1, 1990·Reviews of Infectious Diseases·K W BrammerJ K Faulkner
Aug 1, 1990·Annals of Internal Medicine·J N Galgiani
Nov 1, 1984·Reviews of Infectious Diseases·R A SmegoD T Durack
Aug 1, 1995·Journal of the American Society of Nephrology : JASN·T BerlW L Henrich
Apr 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K W Brammer, P E Coates
Mar 11, 1998·The Pediatric Infectious Disease Journal·A ScarcellaA de Lucia
Mar 28, 1998·Antimicrobial Agents and Chemotherapy·E J AnaissieL A Pietrelli
Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M H WhiteC B Miller
Jan 9, 1999·Clinical Microbiology Reviews·D J SheehanC M Sibley
Aug 3, 1999·Antimicrobial Agents and Chemotherapy·V Novelli, H Holzel
Oct 8, 1999·European Journal of Drug Metabolism and Pharmacokinetics·M C NahataR W Force
Feb 15, 2000·Chemotherapy·A VermesH J Guchelaar
Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M FernandezC J Baker
Aug 23, 2001·International Journal of Antimicrobial Agents·K UchidaH Yamaguchi
Oct 6, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A VillanuevaC A Sable
Jan 5, 2002·The New England Journal of Medicine·D KaufmanL G Donowitz
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·Julie A StoneScott A Waldman
May 9, 2002·International Journal of Pharmaceutics·Rajshree N KotwaniSunil K Pandya
May 11, 2002·The Journal of Antibiotics·Kazuo HatanoFumiaki Ikeda
Jul 19, 2002·Transplant Infectious Disease : an Official Journal of the Transplantation Society·C A SableM J DiNubile
Sep 16, 2003·The Journal of Antimicrobial Chemotherapy·Nehama LinderLea Sirota
Sep 19, 2003·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A Juster-ReicherE Leibovitz
Oct 11, 2003·Lancet·David W Denning
Nov 18, 2003·British Journal of Clinical Pharmacology·Lynn PurkinsDon Nichols
May 18, 2004·Journal of Clinical Pharmacology·James A DowellTim Henkel
May 25, 2004·Antimicrobial Agents and Chemotherapy·Thomas J WalshNolan Wood
Aug 26, 2004·Antimicrobial Agents and Chemotherapy·Philip KrieterRachel Courtney
Nov 17, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jo-Anne H van BurikUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group
Dec 4, 2004·Pediatric Dermatology·Melissa RubensteinDenise Metry
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Nita L SeibelThomas J Walsh
Aug 17, 2005·Infectious Disease Clinics of North America·P Brian SmithDaniel K Benjamin
Aug 30, 2005·The Journal of Pediatrics·Giovanna BertiniFirmino F Rubaltelli

❮ Previous
Next ❯

Citations

Nov 5, 2014·Journal of Chemotherapy·M BaptistaD Virella
Nov 1, 2017·Medical Mycology·Naruhiko IshiwadaKatsuhiko Kamei
Mar 15, 2016·The Pediatric Infectious Disease Journal·Marie Antoinette FrickPere Soler-Palacin
Oct 4, 2012·Expert Review of Anti-infective Therapy·Brian D W ChowJoseph M Bliss
Feb 10, 2021·Antimicrobial Agents and Chemotherapy·Cinzia AuritiManjunath P Pai
Dec 10, 2021·Expert Review of Anti-infective Therapy·Nahed Abdel-HaqBasim I Asmar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Current Opinion in Infectious Diseases
M Cohen-WolkowiezP B Smith
Seminars in Perinatology
Nidhi TripathiDaniel K Benjamin
Current Medical Research and Opinion
D A Kaufman
The Journal of Infection
Rachel G Greenberg, Daniel K Benjamin
© 2022 Meta ULC. All rights reserved